You have 9 free searches left this month | for more free features.

mpdl3280a

Showing 1 - 11 of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NSCLC Trial in Boston, New York (MPDL3280A, Carboplatin, Nab-paclitaxel)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • MPDL3280A
  • +2 more
  • Boston, Massachusetts
  • +1 more
Oct 12, 2022

Locally Advanced or Metastatic Solid Tumors Trial in Groningen (MPDL3280A)

Recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • MPDL3280A
  • Groningen, Netherlands
    University Medical Center Groningen
Feb 28, 2022

Lung Cancer, NSCLC Trial in Houston (MPDL3280A, Carboplatin, Paclitaxel)

Active, not recruiting
  • Lung Cancer
  • Non-Small Cell Lung Cancer
  • MPDL3280A
  • +3 more
  • Houston, Texas
    MD Anderson Cancer Center
Apr 28, 2022

NSCLC Trial in London (MPDL3280A, Vemurafenib, Alectinib)

Recruiting
  • Non-small Cell Lung Cancer
  • MPDL3280A
  • +3 more
  • London, United Kingdom
    Univeristy College London Hospital
Feb 22, 2022

Invasive Ductal Breast Carcinoma Trial in Worldwide (Carboplatin, Abraxane, MPDL3280A)

Active, not recruiting
  • Invasive Ductal Breast Carcinoma
  • Innsbruck, Austria
  • +40 more
Jul 26, 2022

Anal Cancer Trial in France (MPDL3280A, mDCF)

Unknown status
  • Anal Cancer
  • Amiens, France
  • +30 more
Dec 3, 2021

Bladder Cancer Trial in Worldwide (MPDL3280A)

Unknown status
  • Bladder Cancer
  • MPDL3280A
  • Bordeaux, France
  • +19 more
Feb 24, 2020

NSCLC Trial in Santa Monica (Rociletinib, MPDL3280A)

Terminated
  • Non-small Cell Lung Cancer
  • Santa Monica, California
    University of California at Los Angeles
Jun 28, 2019

NSCLC Trial in Ann Arbor, Seattle (MPDL3280A, Hypofractionated Radiotherapy)

Completed
  • Non-small Cell Lung Cancer
  • MPDL3280A
  • Hypofractionated Radiotherapy
  • Ann Arbor, Michigan
  • +1 more
Feb 7, 2019

Small Cell Lung Cancer ( SCLC ) Trial in Washington (Carboplatin, Etoposide, MPDL3280A)

Terminated
  • Small Cell Lung Cancer ( SCLC )
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Jun 29, 2018

NSCLC Trial in New Haven (CDX-1401, MPDL3280A)

Withdrawn
  • Non-Small Cell Lung Cancer
  • New Haven, Connecticut
    Yale University
Jun 21, 2017